Free Express Shipping on Orders $450+ | Peptide of the Week: Tirzepatide - 10% Off This Week

PT-141 Canada Research Guide

PT-141, also known in the scientific literature as Bremelanotide, remains one of the most closely studied melanocortin-system peptides in Canadian laboratory research because it acts through central melanocortin pathways rather than through PDE5-style vascular mechanisms. This guide explains what PT-141 is, why researchers continue to study it in 2026, and what purity, documentation, shipping, and research-only standards matter most when sourcing it in Canada.

Updated: April 23, 2026 Canada Research Guide Melanocortin & Central Signaling Research Research Use Only
Direct Answer

PT-141 is a synthetic melanocortin receptor peptide studied for direct central nervous system signaling through melanocortin pathways, especially MC4R-focused research, with additional interest across the broader melanocortin receptor family. It is valued in laboratory settings because it operates through neurochemical receptor signaling rather than through nitric-oxide or vascular PDE5-type mechanisms.

What this page covers
Melanocortin Receptors
Central Signaling
Behavioral Models
Purity Standards
FAQ

Overview

PT-141 remains important because it gives researchers a peptide model that acts directly through melanocortin receptor signaling instead of acting through peripheral vascular pathways. That difference makes it especially useful in receptor-mapping, central signaling, and behavioral-neurobiology research.

Layman’s Summary

PT-141 is a melanocortin peptide used by researchers to study how the brain and central signaling systems respond to receptor activation. It is fundamentally different from PDE5-type compounds because it is studied for central receptor effects rather than blood-flow mechanisms.

In 2026, PT-141 continues to stand out because it is one of the clearest peptide examples of centrally active melanocortin-pathway research.

Jump to a section

What Is PT-141?

PT-141 is a synthetic melanocortin peptide with the sequence Ac-Nle-c[Asp-His-DNal(2’)-Arg-Trp-Lys]-OH and CAS number 189691-06-3. It is studied as a receptor-active peptide within the melanocortin system, with particular emphasis on central melanocortin signaling.

Why PT-141 is distinct: unlike PDE5-linked compounds, PT-141 is studied for direct receptor-level activity in the central nervous system. That receptor-centered mechanism is the main reason it remains so important in behavioral and neurochemical research.
Peptide Name PT-141
Literature Name Bremelanotide
Class Melanocortin Peptide
CAS 189691-06-3
Main Research Theme Central Receptor Signaling

How PT-141 Works Mechanistically

PT-141 is studied because it engages melanocortin receptor pathways directly, with strong research emphasis on central receptor activation and neural-cascade signaling.

Pathway What Researchers Study Why It Matters
MC4R activation Central melanocortin signaling, behavioral modulation, and neural-cascade activation MC4R is a major focus because of its strong central nervous system relevance.
Broader melanocortin receptor-family interaction Receptor selectivity across melanocortin pathways Helps researchers map where PT-141 sits within the wider melanocortin framework.
Direct central pathway engagement Neurochemical and behavioral pathway activation Distinguishes PT-141 from peripheral vascular research compounds.
Core difference: PT-141 is studied as a centrally acting melanocortin peptide, not as a nitric-oxide or PDE5-style vascular agent. That distinction is one of the main reasons it remains unique in 2026 peptide research.

Why MC4R Research Matters

MC4R remains one of the main receptor systems associated with PT-141 research because it links central melanocortin activity to broader behavioral and neurological pathways.

Main research relevance: PT-141 is valuable because it allows laboratories to study how melanocortin receptor activation influences neural processing, behavioral-response pathways, and central neuropeptide modulation without relying on indirect vascular models.

That receptor-level clarity is one reason PT-141 continues to appear in central nervous system and melanocortin mapping studies.

PT-141 vs Kisspeptin: Quick Research Comparison

PT-141 and Kisspeptin are sometimes compared because both appear in central-signaling research, but the receptor systems they target are different.

Feature PT-141 Kisspeptin
Primary receptor focus Melanocortin system, especially MC4R-focused research GPR54 / Kiss1R
Research category Melanocortin signaling Hypothalamic and reproductive-signaling research
CNS involvement Strong central receptor signaling emphasis Moderate to strong hypothalamic pathway emphasis
Pathway logic Direct receptor agonist framework GnRH-linked modulation framework

Purity, Documentation, and COA Standards

Because PT-141 is commonly used in receptor-level signaling research, Canadian laboratories generally expect strong analytical documentation and batch-level transparency.

Standard Why It Matters
≥99% purity Supports cleaner receptor-binding and signaling studies.
Batch-specific COA Improves traceability and repeatability between lots.
HPLC chromatogram Provides analytical support for purity claims.
Mass spectrometry confirmation Supports molecular identity verification.
Clear labeling and batch tracking Reduces confusion and protects workflow integrity.
A proper PT-141 COA should include: HPLC chromatogram, purity percentage, mass spectrometry identity confirmation, batch or lot number, testing date, laboratory identifier, and molecular-weight verification.

PT-141 Shipping Within Canada

Domestic Canadian sourcing remains important because reduced transit time and more predictable handling help preserve research-material stability.

Main domestic advantages: no customs delays, minimal temperature exposure, faster transit, better lyophilized stability, accurate tracking, and easier support if issues arise.

How PT-141 Is Used in Canadian Labs

PT-141 must remain within a strict research-use-only framework in Canada.

Permitted laboratory contexts include: receptor-binding studies, central-signaling models, melanocortin-pathway mapping, behavioral research models, molecular interaction studies, and controlled biochemical assays.
Not permitted:
Human use
Veterinary use
Dosing instructions
Therapeutic claims
Consumer-health positioning

Red Flags When Buying PT-141 in Canada

Canadian researchers generally avoid suppliers that weaken trust around documentation, labeling, shipping origin, or research-use-only discipline.

Common red flags:
Missing COAs
Generic or non-batch-specific COAs
Unclear or unprofessional labeling
International shipping without notice
Medical or dosing claims
Stock photos instead of real vial images
Long delivery windows suggesting overseas fulfillment
Unclear fulfillment origin

Documentation and transparency remain essential quality signals in this category.

Related Research Guides

These pages extend the broader melanocortin, neurochemical, and research-quality context around PT-141.

Frequently Asked Questions

These answers cover the most common PT-141 research and sourcing questions in 2026.

PT-141 is studied as a centrally acting melanocortin peptide, while PDE5-style compounds are associated with peripheral vascular pathways. Researchers treat these as fundamentally different mechanisms.

PT-141 appears in broader central-signaling and behavioral-response research without being limited to a single sex-specific model, which is one reason it remains relevant in melanocortin-system studies.

Researchers may compare PT-141 against other central-signaling or receptor-targeted compounds in controlled laboratory designs, but any combination framework should remain within strict research-use-only protocols.

Researchers generally keep lyophilized PT-141 under controlled low-temperature storage conditions consistent with standard peptide-handling protocols and supplier guidance, while avoiding repeated freeze-thaw cycles.

Luxara Labs emphasizes ≥99% purity expectations, batch-specific COAs, mass-spectrometry identity confirmation, transparent documentation pages, and strong domestic fulfillment standards so researchers can evaluate the quality framework more clearly.

Research References

These references support the melanocortin, central-signaling, and receptor-selectivity context discussed on this page.

  1. Published melanocortin receptor research on PT-141 and central receptor signaling.
  2. Behavioral and neurochemical pathway studies involving MC4R-focused melanocortin agonism.
  3. Central melanocortin receptor mapping literature relevant to PT-141 / Bremelanotide.
  4. Comparative receptor-pathway discussions distinguishing melanocortin agonists from PDE5-type vascular agents.
Research Use Notice: All information on this page is provided for scientific, educational, and laboratory reference only. PT-141 is intended strictly for research, laboratory, and in-vitro use and is not represented as approved for human or veterinary consumption.

Unlock 10% Off Your First Order

Join our list and get an instant 10% discount code — valid for first-time buyers.

10% Popup Email Opt-in